2,090 research outputs found
Interplay between topology and dynamics in the World Trade Web
We present an empirical analysis of the network formed by the trade
relationships between all world countries, or World Trade Web (WTW). Each
(directed) link is weighted by the amount of wealth flowing between two
countries, and each country is characterized by the value of its Gross Domestic
Product (GDP). By analysing a set of year-by-year data covering the time
interval 1950-2000, we show that the dynamics of all GDP values and the
evolution of the WTW (trade flow and topology) are tightly coupled. The
probability that two countries are connected depends on their GDP values,
supporting recent theoretical models relating network topology to the presence
of a `hidden' variable (or fitness). On the other hand, the topology is shown
to determine the GDP values due to the exchange between countries. This leads
us to a new framework where the fitness value is a dynamical variable
determining, and at the same time depending on, network topology in a
continuous feedback.Comment: Proceedings of the 5th conference on Applications of Physics in
Financial Analysis (APFA5), 29 June - 1 July 2006, Torino (ITALY
Patterns of link reciprocity in directed networks
We address the problem of link reciprocity, the non-random presence of two
mutual links between pairs of vertices. We propose a new measure of reciprocity
that allows the ordering of networks according to their actual degree of
correlation between mutual links. We find that real networks are always either
correlated or anticorrelated, and that networks of the same type (economic,
social, cellular, financial, ecological, etc.) display similar values of the
reciprocity. The observed patterns are not reproduced by current models. This
leads us to introduce a more general framework where mutual links occur with a
conditional connection probability. In some of the studied networks we discuss
the form of the conditional connection probability and the size dependence of
the reciprocity.Comment: Final version accepted for publication on Physical Review Letter
Laue Lens Development for Hard X-rays (>60 keV)
Results of reflectivity measurements of mosaic crystal samples of Cu (111)
are reported. These tests were performed in the context of a feasibility study
of a hard X-ray focusing telescope for space astronomy with energy passband
from 60 to 600 keV. The technique envisaged is that of using mosaic crystals in
transmission configuration that diffract X-rays for Bragg diffraction (Laue
lens). The Laue lens assumed has a spherical shape with focal length . It is
made of flat mosaic crystal tiles suitably positioned in the lens. The samples
were grown and worked for this project at the Institute Laue-Langevin (ILL) in
Grenoble (France), while the reflectivity tests were performed at the X-ray
facility of the Physics Department of the University of Ferrara.Comment: 6 pages, 12 figures, accepted for publication in IEEE Transactions on
Nuclear Scienc
Innate immune modulation by GM-CSF and IL-3 in health and disease
Granulocyte-macrophage colony-stimulating factor (GM-CSF) and inteleukin-3 (IL-3) have long been known as mediators of emergency myelopoiesis, but recent evidence has highlighted their critical role in modulating innate immune effector functions in mice and humans. This new wealth of knowledge has uncovered novel aspects of the pathogenesis of a range of disorders, including infectious, neoplastic, autoimmune, allergic and cardiovascular diseases. Consequently, GM-CSF and IL-3 are now being investigated as therapeutic targets for some of these disorders, and some phase I/II clinical trials are already showing promising results. There is also pre-clinical and clinical evidence that GM-CSF can be an effective immunostimulatory agent when being combined with anti-cytotoxic T lymphocyte-associated protein 4 (anti-CTLA-4) in patients with metastatic melanoma as well as in novel cancer immunotherapy approaches. Finally, GM-CSF and to a lesser extent IL-3 play a critical role in experimental models of trained immunity by acting not only on bone marrow precursors but also directly on mature myeloid cells. Altogether, characterizing GM-CSF and IL-3 as central mediators of innate immune activation is poised to open new therapeutic avenues for several immune-mediated disorders and define their potential in the context of immunotherapies
Innate effector cells in angiogenesis and lymphangiogenesis
Angiogenesis and lymphangiogenesis are distinct and complex processes requiring a finely tuned balance between stimulatory and inhibitory signals. During adulthood, angiogenesis and lymphangiogenesis are activated at sites of tumor growth, tissue injury and remodeling, and chronic inflammation. Vascular endothelial growth factors (VEGFs), angiopoietin (ANGPTs) and a multitude of additional signaling molecules play distinct roles in the modulation of angiogenesis/lymphangiogenesis. VEGFs and ANGPTs activate specific tyrosine kinase receptor (e.g., VEGFR1, VEGFR-2, VEGFR-3 and TIE2 respectively), expressed on blood endothelial cells (angiogenesis) and lymphatic endothelial cells (lymphangiogenesis). Although tumor cells produce VEGFs and other proangiogenic mediators, tissue resident (e.g., macrophages, mast cells) and circulating immune cells (e.g., basophils, neutrophils, monocytes, eosinophils) are an important source of angiogenic/lymphangiogenic mediators in inflammation and in tumor microenvironment and at site of chronic inflammation. Certain immune cells can also release anti-angiogenic factors. Mast cells, basophils, neutrophils and presumably other immune cells are not only a source of angiogenic/lymphangiogenic molecules, but also their target. Cells of the immune system need consideration as major players and possible targets for therapeutic manipulation of angiogenesis/lymphangiogenesis in chronic inflammatory disorders and tumors
Long-term prediction of adherence to continuous positive air pressure therapy for the treatment of moderate/severe obstructive sleep apnea syndrome
BACKGROUND: Continuous positive airway pressure (CPAP) therapy is a highly effective treatment for obstructive sleep apnea syndrome (OSAS). However, poor adherence is a limiting factor, and a significant proportion of patients are unable to tolerate CPAP. The aim of this study was to determine predictors of long-term non-compliance with CPAP.
METHODS: CPAP treatment was prescribed to all consecutive patients with moderate or severe OSAS (AHI ≥15 events/h) (n = 295) who underwent a full-night CPAP titration study at home between February 1, 2002 and December 1, 2016. Adherence was defined as CPAP use for at least 4 h per night and five days per week. Subjects had periodical follow-up visits including clinical and biochemical evaluation and assessment of adherence to CPAP.
RESULTS: Median follow-up observation was 74.8 (24.2/110.9) months. The percentage of OSAS patients adhering to CPAP was 41.4% (42.3% in males and 37.0% in females), and prevalence was significantly higher in severe OSAS than in moderate (51.8% vs. 22.1%; p < 0.001; respectively). At multivariate analysis, lower severity of OSAS (HR = 0.66; CI 95 0.46-0.94) p < 0.023), cigarette smoking (HR = 1.72; CI 95 1.13-2.61); p = 0.011), and previous cardiovascular events (HR = 1.95; CI 95 1.03-3.70; p = 0.04) were the only independent predictors of long-term non-adherence to CPAP after controlling for age, gender, and metabolic syndrome.
CONCLUSIONS: In our cohort of patients with moderate/severe OSAS who were prescribed CPAP therapy, long-term compliance to treatment was present in less than half of the patients. Adherence was positively associated with OSAS severity and negatively associated with cigarette smoking and previous cardiovascular events at baseline
Superantigenic Activation of Human Cardiac Mast Cells.
B cell superantigens, also called immunoglobulin superantigens, bind to the variable regions of either the heavy or light chain of immunoglobulins mirroring the lymphocyte-activating properties of classical T cell superantigens. Protein A of Staphylococcus aureus, protein L of Peptostreptococcus magnus, and gp120 of HIV are typical immunoglobulin superantigens. Mast cells are immune cells expressing the high-affinity receptor for IgE (FcεRI) and are strategically located in the human heart, where they play a role in several cardiometabolic diseases. Here, we investigated whether immunoglobulin superantigens induced the activation of human heart mast cells (HHMCs). Protein A induced the de novo synthesis of cysteinyl leukotriene C4 (LTC4) from HHMCs through the interaction with IgE VH3+ bound to FcεRI. Protein L stimulated the production of prostaglandin D2 (PGD2) from HHMCs through the interaction with κ light chains of IgE. HIV glycoprotein gp120 induced the release of preformed (histamine) and de novo synthesized mediators, such as cysteinyl leukotriene C4 (LTC4), angiogenic (VEGF-A), and lymphangiogenic (VEGF-C) factors by interacting with the VH3 region of IgE. Collectively, our data indicate that bacterial and viral immunoglobulin superantigens can interact with different regions of IgE bound to FcεRI to induce the release of proinflammatory, angiogenic, and lymphangiogenic factors from human cardiac mast cells.This work was supported in part by grants from Regione Campania CISI-Lab Project, CRèME Project, and TIMING Project
Heterogeneity of Human Mast Cells With Respect to MRGPRX2 Receptor Expression and Function.
Mast cells and their mediators play a role in the control of homeostasis and in the pathogenesis of several disorders. The concept of rodent mast cell heterogeneity, initially established in the mid-1960s has been extended in humans. Human mast cells isolated and purified from different anatomic sites can be activated via aggregation of cell surface high affinity IgE receptors (FcεRI) by antigens, superantigens, anti-IgE, and anti-FcεRI. MAS-related G protein-coupled receptor-X2 (MRGPRX2) is expressed at high level in human skin mast cells (MCs) (HSMCs), synovial MCs (HSyMCs), but not in lung MCs (HLMCs). MRGPX2 can be activated by neuropeptide substance P, several opioids, cationic drugs, and 48/80. Substance P (5 × 10-7 M - 5 × 10-6 M) induced histamine and tryptase release from HSMCs and to a lesser extent from HSyMCs, but not from HLMCs and human cardiac MCs (HHMCs). Morphine (10-5 M - 3 × 10-4 M) selectively induced histamine and tryptase release from HSMCs, but not from HLMCs and HHMCs. SP and morphine were incomplete secretagogues because they did not induce the de novo synthesis of arachidonic acid metabolites from human mast cells. In the same experiments anti-IgE (3 μg/ml) induced the release of histamine and tryptase and the de novo synthesis of prostaglandin D2 (PGD2) from HLMCs, HHMCs, HSyMCs, and HSMCs. By contrast, anti-IgE induced the production of leukotriene C4 (LTC4) from HLMCs, HHMCs, HSyMCs, but not from HSMCs. These results are compatible with the heterogeneous expression and function of MRGPRX2 receptor on primary human mast cells isolated from different anatomic sites.This work was supported partly by grants from the Regione Campania CISI-Lab Project, CRèME Project and TIMING Project
Development status of a Laue lens project for gamma-ray astronomy
We report the status of the HAXTEL project, devoted to perform a design study
and the development of a Laue lens prototype. After a summary of the major
results of the design study, the approach adopted to develop a Demonstration
Model of a Laue lens is discussed, the set up described, and some results
presented.Comment: 11 pages, 11 figures, 2007 SPIE Conference on Optics for EUV, X-Ray,
and Gamma-Ray Astronomy II
- …